Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Non-Invasive Wearable Sensor Detects Sweat Biomarker in Low-Perspiration Conditions

By HospiMedica International staff writers
Posted on 24 Sep 2025

Sweat is an appealing medium for health monitoring because it is readily available and contains multiple biomarkers. More...

However, most existing devices fail when perspiration is minimal, which limits their use in critically ill patients or individuals at rest. This makes it difficult to track key biomarkers such as lactate, which can indicate oxygen deprivation in tissues, a warning sign for conditions like sepsis, organ failure, or poor athletic performance. Now, a novel wearable sensor can continuously monitor low rates of perspiration for the presence of lactate, a molecule used by the body to break down sugars for energy.

The new wearable sensor has been developed by researchers at Penn State (University Park, PA, USA) to work under low-sweat conditions. The device, about the size of a band-aid, uses granular hydrogels combined with laser-induced graphene (LIG) patterned into a compact spiral microfluidic chamber. This design increases absorption capacity, minimizes liquid loss, and ensures lactate molecules reach the sensor even when sweat production is extremely low.

Unlike conventional hydrogels, the granular hydrogel scaffold features porous microscale particles with void spaces that enhance capillary-driven absorption. This allows the device to collect up to 10 times more sweat during low-intensity activities such as walking, working at a desk, or even lying down. Attached comfortably with skin-safe adhesive, it mimics a “skin-like” feel and enables continuous, non-invasive monitoring.

In trials, the flexible sensor was applied to participants during daily activities, sedentary office work, and exercise. The results, published in the journal Small, showed the device could consistently capture enough sweat to measure lactate within two hours. This proof-of-concept confirmed the accuracy, sensitivity, and practicality of the design, setting it apart from earlier sweat sensors that required more perspiration to function effectively.

The platform offers significant potential for early biomarker detection in both clinical and fitness settings. Its versatility means the sensor could be adapted to detect other biomarkers beyond lactate, providing broader applications in personalized health monitoring. Future research aims to refine the device and expand its use for continuous, real-time, and cost-effective health tracking across diverse populations.

“The proof-of-concept demonstration features a cost-effective, sensitive and versatile flexible sensing platform for early biomarker detection, where sweat production is minimal or sporadic, such as at rest or during mild physical activities,” said Farnaz Lorestani, co-first author of the study. “Overall, our goal is to build a healthier society by making non-invasive, continuous, personalized health monitoring more accessible to everyone — and this work is a step in that direction.”

Related Links:
Penn State


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.